Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer

I tiakina i:

Ngā taipitopito rārangi puna kōrero
I whakaputaina i:	NPJ Breast Cancer vol. 10, no. 1 (2024), p. 28
Kaituhi matua:	Morganti, Stefania
Ētahi atu kaituhi:	Jin, Qingchun, Vincuilla, Julie, Buehler, Ryan, Ryan, Sean, Stokes, Samantha, Parker, Tonia, Mittendorf, Elizabeth A., King, Tari A., Weiss, Anna, Partridge, Ann H., Bychkovsky, Brittany L., Curigliano, Giuseppe, Tayob, Nabihah, Lin, Nancy U., Garber, Judy E., Tolaney, Sara M., Lynce, Filipa
I whakaputaina:	Nature Publishing Group
Ngā marau:	Genetic testing Oncology Tumors Surgery Cancer therapies Chemotherapy Breast cancer
Urunga tuihono:	Citation/Abstract Full Text - PDF
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!